Replies to post #27758 on Curative Biotechnology Inc (CUBT)

[KOmani]

My understanding is that this is the follow up to the news from July 06 ...

And, it says they received the grant of license from the NIH, not that they sent out an application today.

Perhaps today's news along with last week's news finally hit the shares price today.

Only time will tell.

[Mooseface]

You're getting bogged down in the wording of the pr. It's pretty simple. There's no investigating or application process here, they spent the last three months going through that. They were granted a license from the NIH... They now have 2 licenses under their belt. Current market cap is way too low, going up next week.

[Fai 2]

You can call the CEO anytime or contact him via linkedln. Check the last two press release his number is there.



Paul M Michaels - Chief Executive Officer - Connectyx Technologies


For the past two decades, established lasting relationships with key business leaders and stakeholders in Japan and the U.S., particularly in the Life Sciences field Expertise in financing, risk management, global business development, mergers and acquisitions and cross-border pharmaceutical licensing. Completed transactions that influenced companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and…